Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is supported by a Phase 2 study… Read More
The Vancouver Coastal Health Research Institute (VCHRI), in partnership with Vancouver Coastal Health (VCH) and the VGH & UBC Hospital Foundation, is launching the Phase 1 Clinical Trials Research Unit (P1-CTRU)… Read More
The incredible support and generosity shown at the 19th Annual Scotiabank Feast of Fortune has left a lasting mark – one that will shape the future of health care for… Read More
The first and only innovation of its kind to receive 510(k) clearance, Surgiphor™ 1000mL empowers surgical teams with a consistent, antimicrobial solution designed to improve patient care and operating room… Read More
Combination demonstrates deep PSA responses and favorable safety profile with plans to advance into Phase 3 Data highlight the potential of this first-in-class next-generation T-cell engager to expand the role… Read More
